These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26930597)

  • 1. Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves.
    Feng X; Ma JW; Sun SQ; Guo HC; Yang YM; Jin Y; Zhou GQ; He JJ; Guo JH; Qi SY; Lin M; Cai H; Liu XT
    PLoS One; 2016; 11(3):e0149569. PubMed ID: 26930597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine.
    Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP
    J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.
    Van Maanen C; Terpstra C
    Biologicals; 1990 Oct; 18(4):315-9. PubMed ID: 2178351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs.
    Cao Y; Zhou W; Xing X; Zhang J; Fu Y; Li K; Sun P; Li P; Bai X; Ma X; Bao H; Li D; Chen Y; Lu Z; Liu Z
    J Virol Methods; 2018 Dec; 262():26-31. PubMed ID: 30244034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.
    Cao Y; Li K; Wang S; Fu Y; Sun P; Li P; Bai X; Zhang J; Ma X; Xing X; Zhou S; Bao H; Li D; Chen Y; Li Z; Lu Z; Liu Z
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus.
    Mackay DK; Bulut AN; Rendle T; Davidson F; Ferris NP
    J Virol Methods; 2001 Sep; 97(1-2):33-48. PubMed ID: 11483215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.
    Naveed A; Rahman SU; Arshad MI; Aslam B
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a double-antibody sandwich ELISA for rapidly quantitative detection of residual non-structural proteins in inactivated foot-and-mouth disease virus vaccines.
    Fu Y; Li D; Cao Y; Zhou P; Li K; Zhao Z; Li P; Bai X; Bao H; Wang S; Zhao L; Wang X; Liu Z; Sun P; Lu Z
    J Virol Methods; 2023 Apr; 314():114676. PubMed ID: 36669654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals.
    Basagoudanavar SH; Hosamani M; Tamil Selvan RP; Sreenivasa BP; Saravanan P; Chandrasekhar Sagar BK; Venkataramanan R
    Arch Virol; 2013 May; 158(5):993-1001. PubMed ID: 23242775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
    Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
    Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
    Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture.
    Yang M; Holland H; Clavijo A
    Vaccine; 2008 Jun; 26(27-28):3377-82. PubMed ID: 18513841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and development of a sandwich ELISA for virus antigen detection.
    Mallick S; Singh RP; Biswal JK; Mohapatra JK; Rout M; Samanta R; Khulape SA; Ranjan R
    Vet Res Commun; 2023 Dec; 47(4):1915-1924. PubMed ID: 37222940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    Mansilla FC; Turco CS; Miraglia MC; Bessone FA; Franco R; Pérez-Filgueira M; Sala JM; Capozzo AV
    PLoS One; 2020; 15(5):e0232782. PubMed ID: 32369529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a sandwich ELISA for detecting 3AB non-structural protein of foot-and-mouth disease virus].
    Fu Y; He W; Sun P; Yang L; Bao H; Cao Y; Bai X; Li P; Li D; Chen Y; Liu L; Lu Z; Liu Z
    Sheng Wu Gong Cheng Xue Bao; 2020 Nov; 36(11):2357-2366. PubMed ID: 33244930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.
    Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV
    Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.